Navigation Links
Digitek Medication Recalled Due to Risk of Digitalis Toxicity
Date:8/18/2009

EDISON, N.J.,, Aug. 18 /PRNewswire/ -- Digitek Medication: Digitek (digoxin tablets) is a widely-used medication used to treat various heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial flutter), and heart failure. Digitek is a powerful drug, which is so potent that even a slight increase in dosage can be toxic or fatal.

If you or a loved one has suffered digitalis toxicity or symptoms associated with digitalis toxicity as a result of taking Digitek, you should contact Eichen Levinson & Crutchlow (http://www.eichenlevinson.com/) to evaluate your claim. You may be entitled to compensation for medical expenses, loss of wages, and pain and suffering. Eichen's Digitek attorneys are able to handle and litigate Digitek cases no matter where you live

Digitek Recall: Following repeated Food and Drug Administration (FDA) criticisms of its manufacturing processes, the pharmaceutical company, Actavis Totowa issued a Class I nationwide drug recall for all lots of Digitek (digoxin) on the grounds that some tablets may contain twice the approved level of the active ingredient. A Class I recall is the most dangerous type of FDA recall. Even though the drugs are sold under different brand names, they are essentially the same product with the same active ingredient. Therefore, the recall pertains to Digitek tablets (all strengths) distributed by Mylan Pharmaceuticals and sold under the label "Bertek", as well as Digitek distributed by UDL Laboratories, Inc. and sold under the label "UDL".

Digitalis Toxicity Signs & Symptoms may include the following:

  • Visual changes, for example
    • Halos or rings of light around objects
    • Seeing lights or bright spots
    • Changes in color perception
    • Blind spots in vision
    • Blurred vision
  • Confusion
  • Loss of appetite
  • Nausea, vomiting, diarrhea
  • Palpitations
  • Irregular Pulse
  • Decreased urine output
  • Excessive nighttime urination
  • Overall Swelling
  • Decreased consciousness
  • Difficulty breathing when lying down

To evaluate your Digitek claim, contact Eichen Levinson & Crutchlow, with offices located in Edison, New Jersey and Toms River, New Jersey, provides award-winning legal services in the tri-state area and nationally in matters involving catastrophic personal injury, mass torts, medical malpractice, class actions, and consumer fraud litigation.

    Contact: Angela McKillop
    Amckillop@eichenlevinson.com
    EichenLevinson .com
    Tel: (732) 777-0100
    Fax: (732) 248-8273


'/>"/>
SOURCE Eichen Levinson & Crutchlow, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims
2. National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan
3. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
4. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
5. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
6. Manic phase of bipolar disorder benefits from breast cancer medication
7. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
8. Mayo Clinic study indicates medication for ADHD may help student outcomes
9. Diet and medications may assist prevention of prostate cancer
10. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
11. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to ... Medical Informatics . , Results of the comparative usability study demonstrate that a ...
(Date:12/8/2016)... ... 2016 , ... With the increasing demand for dental implants, the National Association ... to inform dentists and patients about the safety issues related to dental restorations. According ... the U.S. is projected to reach $6.4 billion in 2018 with more than 30 ...
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into ... claim in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th ... According to the study, medical payments per claim in California decreased 4 percent in ...
(Date:12/8/2016)... Rock, AR (PRWEB) , ... December 08, 2016 ... ... providing insurance and financial planning services from offices headquartered in Little Rock, has ... Food Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition of the ... Application, Usability - Forecast to 2025" report to their offering. ... , , ... grow at a CAGR of around 3.2% from 2015 to 2025. ... advancements in extracellular microelectrode arrays and intracellular microelectrodes, research in left-to-right ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: